PATENT CLAIM ANALYSIS

Application Number: 16012197
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "325000"]

Abstract:
The disclosure is directed to the use of nonviable pluripotent stem cells to improve age-related declines in tissue and organ function. In one aspect, nonviable pluripotent stem cells are used to improve cognition in a subject in need thereof. In another aspect, nonviable pluripotent stem cells are used to improve age-related cardiac dysfunction in a subject in need thereof. Administration of nonviable pluripotent stem cells provides a transient and safe form of heterochronic cellular transbiosis.

Claim (Index 7):
The method according to  claim 1 , wherein the nonviable pluripotent stem cells are lethally irradiated pluripotent stem cells.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 94.0
- Lexical Diversity: 1.88372
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15200303', '14280278', '13800281', '15961618', '15499694']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6287974431896156
- 35 USC 102 Novelty (BERT): 0.5336955746538595
- Combined Prediction Score: 0.61928725633604
- Mean Citation Score: 265.87868000000003
- Max Citation Score: 318.66983
- Similarity Product: 258.78394117402735

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test